NCT06469112Completed
The Effect of Vibration on Pain During Subcutaneous Heparin Injection
The Effect of Vibration on Pain During Subcutaneous Heparin Injection: A Randomized Controlled Study
Source: ClinicalTrials.gov · Last updated 6 Apr 2025
Brief summary (registry, in English)
Aim: The aim of this research will to examine the effect of the local vibration technique applied to the injection site during subcutaneous low molecular weight heparin (LMWH) injection. Methods: The patients will randomly assigned to an experimental (vibration) group , a placebo control group, and a nonintervention control group. Participants in the experimental group will give slight vibration to the injection site before the injection will administered; for participants in the placebo group, the device will placed on the injection site but with the vibration button kept switched off, while for the nonintervention control group, routine subcutaneous low molecular weight heparin injection will administered. The level of pain felt by the participants during the administration of the injection will assess with a visual analog scale.
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 93 (actual)
- First submitted
- 16 Jun 2024
- Start date
- 1 Dec 2023
- Primary completion date
- 14 May 2024
- Lead sponsor
- Uludag University
- Diseases
- Asthma
- NCT number
- NCT06469112
What you commit to
- Study type: Interventional
- Participants enrolled: 93
- From 1 Dec 2023 to the primary completion date, 14 May 2024
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- having diabetes mellitus
- peripheral vascular disease, etc. which could affect the perception of pain
Age
- being under the age of 18
Other
- not being conscious, refusing to participate in the research or opting to leave the study at any point.
Who the study is looking for
- being over the age of 18
- having a doctor's prescription for subcutaneousheparin 0.6 mL treatment with a ready-to-use syringe and not yet having begun treatment
- having no coagulation disorder
- having no disorder which could affect pain perception,
- having no incision, lipodystrophy or finding of infection at the injection site,
- having no communication problem, and voluntarily agreeing to participate in the research
Age in the registry: 18 years to 85 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Bursa Uludağ University Hospital Coordinator of this site? Confirm its status | Bursa | Turkey (Türkiye) | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.